BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20799992)

  • 1. The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.
    Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I
    Behav Brain Funct; 2010 Aug; 6():50. PubMed ID: 20799992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of the adenosine A1 receptor gene polymorphisms in patients with methamphetamine dependence/psychosis.
    Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I
    Curr Neuropharmacol; 2011 Mar; 9(1):137-42. PubMed ID: 21886579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.
    Kishi T; Tsunoka T; Ikeda M; Kitajima T; Kawashima K; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Neuropharmacology; 2010 Feb; 58(2):452-6. PubMed ID: 19747927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
    Ikeda M; Okahisa Y; Aleksic B; Won M; Kondo N; Naruse N; Aoyama-Uehara K; Sora I; Iyo M; Hashimoto R; Kawamura Y; Nishida N; Miyagawa T; Takeda M; Sasaki T; Tokunaga K; Ozaki N; Ujike H; Iwata N
    Neuropsychopharmacology; 2013 Sep; 38(10):1864-70. PubMed ID: 23594818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
    Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
    J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population.
    Kishi T; Fukuo Y; Okochi T; Kitajima T; Kawashima K; Naitoh H; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Drug Alcohol Depend; 2011 Jan; 113(1):1-7. PubMed ID: 20705401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.
    Okochi T; Kishi T; Ikeda M; Kitajima T; Kinoshita Y; Kawashima K; Okumura T; Tsunoka T; Inada T; Yamada M; Uchimura N; Iyo M; Sora I; Ozaki N; Ujike H; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):903-5. PubMed ID: 19394386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence.
    Iamjan SA; Thanoi S; Watiktinkorn P; Nudmamud-Thanoi S; Reynolds GP
    Pharmacogenomics; 2015; 16(14):1541-5. PubMed ID: 26401760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis of delta-opioid receptor gene polymorphisms in methamphetamine dependence/psychosis.
    Kobayashi H; Hata H; Ujike H; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Ozaki N; Itokawa M; Naka M; Ide S; Ikeda K; Numachi Y; Sora I
    Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):482-6. PubMed ID: 16741914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence.
    Morio A; Ujike H; Nomura A; Tanaka Y; Morita Y; Otani K; Kishimoto M; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():411-7. PubMed ID: 17105939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis.
    Ujike H; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Sora I; Iyo M; Katsu T; Nomura A; Nakata K; Ozaki N
    Pharmacogenomics J; 2003; 3(4):242-7. PubMed ID: 12931138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
    Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Iyo M; Sora I; Sekine Y; Ozaki N; Ujike H; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():63-9. PubMed ID: 18991850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic vulnerability of methamphetamine dependence].
    Moriya Y; Kasahara Y; Sora I
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):155-60. PubMed ID: 25069251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association analysis of the tryptophan hydroxylase 2 gene polymorphisms in patients with methamphetamine dependence/psychosis.
    Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I
    Curr Neuropharmacol; 2011 Mar; 9(1):176-82. PubMed ID: 21886586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic association studies of methamphetamine use disorders: A systematic review and synthesis.
    Bousman CA; Glatt SJ; Everall IP; Tsuang MT
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1025-49. PubMed ID: 19219857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.
    Kinoshita Y; Ikeda M; Ujike H; Kitajima T; Yamanouchi Y; Aleksic B; Kishi T; Kawashima K; Ohkouchi T; Ozaki N; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iyo M; Sora I; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():57-62. PubMed ID: 18991849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.
    Zhang W; Liu H; Deng XD; Ma Y; Liu Y
    Ann Hum Genet; 2020 May; 84(3):259-270. PubMed ID: 31789429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependence.
    Veerasakul S; Watiktinkorn P; Thanoi S; Dalton CF; Fachim HA; Nudmamud-Thanoi S; Reynolds GP
    Pharmacogenomics; 2017 Sep; 18(14):1317-1322. PubMed ID: 28835159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study between casein kinase 1 epsilon gene and methamphetamine dependence.
    Kotaka T; Ujike H; Morita Y; Kishimoto M; Okahisa Y; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2008 Oct; 1139():43-8. PubMed ID: 18991847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis.
    Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Tsunoka T; Okumura T; Inada T; Ujike H; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):895-8. PubMed ID: 19386276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.